Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
暂无分享，去创建一个
M. Vignetti | M. Voso | S. Hohaus | G. Leone | C. Mecucci | C. Finelli | P. Musto | E. Angelucci | V. Santini | C. Matteucci | L. Brandimarte | G. Fioritoni | A. Piciocchi | E. Pogliani | M. Criscuolo | E. Fabiani | L. Fianchi | M. Greco | E. M. Pogliani | C. Mecucci | Lucia Brandimarte | Emanuele Angelucci | P. Musto | Santini | Giuseppe Leone | E. Pogliani